Amedisys Reports Fourth Quarter and Year End Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks gain, oil prices slide
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Amedisys (AMED) Could Help Transform Healthcare - Mizuho
March 10, 2016 7:39 AM ESTMizuho analyst, Sheryl Skolnick, thinks Amedisys Inc's (NASDAQ: AMED) turnaround continues to impress as it proceeds on multiple fronts, driving better than expected 4Q15 results, meaningful 2016 improvements and likely strong 2017 growth. Increasing transparency into the progress, costs, timing and returns to the turnaround strategies are making the Street increasingly confident and supported a strong move in the stock. The analyst thinks AMED is strongly positioned not only as a post-acute... More
Amedisys (AMED) Tops Q4 EPS by 5c
March 9, 2016 6:24 AM ESTAmedisys (NASDAQ: AMED) reported Q4 EPS of $0.40, $0.05 better than the analyst estimate of $0.35. Revenue for the quarter came in at $337.3 million versus the consensus estimate of $322.01 million.
Earnings before interest, taxes, depreciation and amortization attributable to continuing operations (EBITDA) of $27.6 million compared to $22.9 million in... More
